Envarsus® is a once daily prolonged-release tablet containing tacrolimus monohydrate. The product is indicated for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and for treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.